The role of novel minimally invasive treatments for lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH).

To provide an update on novel minimally invasive LUTS/BPH treatments in a non-systematic review. To define potential target populations for the various new minimally invasive treatments.

Recent literature, meta-analyses and guideline recommendations for aquablation (AquaBeam® ), water vapour thermal therapy (Rezūm® ), prostate artery embolization (PAE), prostatic urethral lift (UroLift® ) and the nitinol butterfly-like stent (i-TIND® ) were reviewed.